Clustering of metabolic disorders and hyperinsulinemia in Mexico City

International Journal of Obesity

Volumn 20, Issue 4, 1996, Pages 311-318

  Zamora Gonzalez J ^a   Yamamoto Kimura, L ^b   Lerman Garber, I ^c   Cardoso Saldana G ^a   Fajardo Gutierrez, A ^d   Posadas Romero, C ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Atherosclerosis; Coronary risk factors; Hyperinsulinemia

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; BODY BUILD; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLUSTER ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC DISORDER; MEXICO; MULTIPLE REGRESSION; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; LIPOPROTEIN(A); LIPOPROTEINS, HDL; MALE; MEXICO; MIDDLE AGED; RANDOM ALLOCATION; RISK FACTORS; TRIGLYCERIDES;

EID: 0029879841     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. DeFronzo RA, Ferranini E. Insulin resistance: multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 73-194.
2. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
3. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 807-817.
4. Dirección General de Estadística e Informática. Mortalidad 1993. México, D.F. Secretaria de Salud 1994.
5. Lozano AR, Escamilla JA, Escobedo J, López-Cervantes M. Tendencia de la mortalidad por cardiopatía isquémica en México de 1950 a 1985. Sal Publ Mex 1990; 32: 405.
6. Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose and lipids: does plasma insulin explain their relationship? Arteriosclerosis 1987; 7: 197-202.
7. Alberti KGMM, Dowse G, Finch, Zimmet P, Gareeboo H, Brigham L. Mauritius NCD study group: is blood pressure related to peripheral insulin levels? A community study in Mauritius [Abstract]. Diabetes 1989; 38: 92A.
8. Mbanya JCN, Thomas TH, Wilkinson R, Alberti KGMM, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but no in essential hypertension. Lancet 1988; 1: 733-734.
9. Jarret RJ. In defense of insulin: a critique of syndrome X. Lancet 1992; 340: 469-471.
10. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk in non-diabetics. Metabolism 1988; 37: 338-345.
11. Ferranini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Padrinelli T, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
12. Foster DW. Insulin resistance: a secret killer? N Engl J Med 1987; 320: 733-734.
13. Saad MG, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991; 324: 733-739.
14. Cruicshank JK, Cooper J, Burnett M, MacDuff J, Dubra U. Ethnic differences in fasting C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991; 338: 842-847.
15. Posadas RC, Yamamoto KL, Lerman GI, Zamora GJ, Fajardo GA, Velazquez PL, Cardoso SG. The prevalence of NIDDM and associated coronary risk factors in Mexico City. Diabetes Care 1994; 17: 1441-1448.
16. Mantel N, Haenszel W. Statical aspects of the analysis of data from retrospectives studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
17. Kaplan NM. The deadly quartet:upper-body obesity, glucose intolerance, hypertrigliceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520.
18. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia 1992; 35: 766-770.
19. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as predictor of coronary heart disease: interaction with apo E phenotype. A report from MRFIT. Ann Epidemiol 1994; 4: 40-45.
20. Ferrara A, Barret-Connor L, Edelstein SL. Hyperinsulinemia does not increased the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 1994; 140: 857-869.
21. Zavaroni I, Bonara E, Pagliara M, Dall'Aglio E, Lucheti I, Buonanno G, Bonati PA, Beragonzani M, Gundi L, Passeri M, Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-706.
22. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986; 6: 123-130.
23. Reaven GM, Hoffman BB. A role for insulin in the etiology and course of hypertension? Lancet 1987; 2: 435-436.
24. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension 1985; 7: 702-706.
25. Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G, Pacifico A. Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment. Am J Hyperten 1990; 3: 521-526.
26. Botiko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY. Visceral adiposity, fasting plasma insulin and blood pressure in Japanese Americans. Diabetes Care 1995; 18: 174-181.
27. Mitchell BD, Hazuda HP, Haffner SM, et al. Myocardial infarction in Mexican Americans and non-Hispanic whites: the San Antonio heart study. Circulation 1991; 83: 43-51.
28. Asch S, Wingard DL, Barrett-Connor EL. Are insulin and hypertension independently related? Ann Epidemiol 1991; 1: 231-244.
29. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 1983; 118: 326-337.
30. Hornick CA, Fellmeth BD. High density lipoprotein cholesterol, insulin and obesity in Samoans. Atherosclerosis 1981; 39: 321-328.
31. Stalder M, Pometta D, Suenram A. Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 1981; 21: 544-548.
32. Laakso M, Pyörälä K, Voutilainen E, Marniemi J. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 1987; 125: 611-621.
33. Haffner SM, Gruber KK, Morales PA, Hazuda HP, Valdez RA, Mitchell BD, Stern MP. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: The San Antonio heart study. Am J Epidemiol 1992; 136: 1060-1068.
34. Duell BP, Hagemenas F, Connor WE: The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care 1994; 17: 1135-1140.
35. Haffner S, Kanhapaa P, Rainwater DL, Mykkanen L, Aldrete G, Laakso M. Insulin sensitivity and Lp(a) concentrations in normoglycemic men. Diabetes Care 1995; 18: 193-199.
36. Labeur C, De Bacquer D, De Backer G, Vince J, Muyldermans L, Vandekerckhove Y, Van Der Stichele E, Rosseneu M. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem 1992; 38: 2262-2266.
37. Sicre RA, Zimmet PZ, King HOM, Coventry JS. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over six years. Diabetes 1987; 36: 179-186.
38. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
39. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 1986; 78: 1648-1657.
40. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13-year follow up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-404.
41. 2: but similar beta-adrenergic receptor activities in subcutaneous gluteal adipocytes females compared with males. Eur J Clin Invest 1986; 16: 302-309.
42. Cigolini M, Seidell JC, Charzewska J, Ellsinger BR, DiBiase G, Björntorp P, Hautvast JGAJ, Contaldo F, Szostak V, Scuro LA. Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women: the European fat distribution study. Metabolism 1991; 40: 781-787.
43. Haffner SM, Stern MP Hazuda HP, et al. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1986; 315: 220-224.
44. Haffner SM, Stern MP Hazuda HP, et al. Do upper body and centralized adiposity measure different aspects of regional body fat distribution? Relationship to non-insulin-dependent diabetes mellitus lipids and lipoproteins. Diabetes 1987; 36: 42-52.
45. Stern MP, Gonzalez C, Mitchell BD, Villalpando E, Haffner SM, Hazudda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992; 41: 484-492.
46. Antonis A, Bersohn J. The influence of diet on serum triglycerides in South African white and Bantu prisoners. Lancet 1961; 1: 3-9.
47. Ginsberg H, Olefsky JM, Kimmering G, Crapo P, Reaven GM. Induction of hypertriglyceridemia by low-fat diet. J Clin Endocrinol Metab 1976; 42: 729-735.
48. Coulston AM, Liu GC, Reaven GM. Plasma glucose, insulin, and lipid responses to high-carbohydrate low-fat diets in normal humans. Metabolism 1983; 32: 52-56.
49. Zimmet P, Dowse G, Finch C, Serjeantson S, King H: The Epidemiology and Natural History of NIDDM. Lessons from the South Pacific. Diabetes Metab Rev 1990; 6: 91-124.